z-logo
open-access-imgOpen Access
Why not change the therapy of hypertension in patients with COVID-19. Dual role of angiotensin-converting enzyme 2
Author(s) -
Teresa Kosicka,
Jerzy Głuszek
Publication year - 2022
Publication title -
arterial hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.112
H-Index - 9
eISSN - 2449-6170
pISSN - 2449-6162
DOI - 10.5603/ah.a2021.0014
Subject(s) - medicine , angiotensin converting enzyme 2 , disease , angiotensin converting enzyme , covid-19 , renin–angiotensin system , death toll , virus , angiotensin ii , angiotensin receptor blockers , enzyme , immunology , intensive care medicine , receptor , blood pressure , biology , infectious disease (medical specialty) , environmental health , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here